News

Systemair Strengthens Sustainability with New Emission Goals

Systemair Strengthens Sustainability with New Emission Goals

Systemair Emission Targets Approved by Science Based Targets Initiative

Systemair recently achieved a significant milestone in its sustainability efforts by having its emission reduction targets officially validated by the Science Based Targets Initiative (SBTi). This globally recognized initiative focuses on ensuring that corporate climate targets align with scientific guidelines aimed at curbing global warming to manageable levels.

CEO Roland Kasper remarked, "Having our emissions targets approved by the SBTi is a strong endorsement of our commitment to sustainability." This approval serves as a testament to Systemair's dedicated approach toward managing emissions across its operations.

Emission Reduction Commitment for the Future

Systemair's strategy involves comprehensive targets for both short-term and long-term emissions reductions. The company aims to tackle emissions from its operations, categorized as scopes 1 and 2, as well as indirect emissions throughout its value chain, referred to as scope 3. Specifically, Systemair has set forth the following goals:

  • Achieve a reduction of absolute emissions in scopes 1 and 2 by 42% by the fiscal year 2030/31, compared to its base year of 2023/24.
  • Lower absolute emissions from scope 3, which includes emissions generated from the use of sold products, by 25% within the same period.
  • In the long-term vision, the goal is to reduce overall emissions (scopes 1, 2, and 3) by 90% and achieve net-zero greenhouse gas emissions by the fiscal year 2050/51.

A staggering 96% of Systemair's emissions emerge from the operational period of sold products, attributed largely to the use of fossil fuels in various countries’ electricity generation. This insight emphasizes the importance of transitioning to cleaner energy sources.

Importance of Energy Efficiency

Energy efficiency has been integral to Systemair's mission since its inception. Lee Morgan, Group Sustainability Director, emphasizes, "Even in regions where fossil-free electricity is available, the importance of energy efficiency cannot be overstated. As we seek to eliminate fossil fuel dependency through alternative technologies, we must minimize energy consumption to allow sufficient emission-free electricity for all. Energy efficiency is crucial for achieving these objectives."

With buildings accounting for about 40% of overall energy demands in society, Systemair recognizes the role it must play in the broader effort to reduce emissions and engage in climate change mitigation.

Understanding the Science Based Targets Initiative

The Science Based Targets Initiative (SBTi) is a global organization that assists businesses in establishing ambitious emission reduction goals based on rigorous scientific research. The initiative's mission is to inspire companies to significantly reduce emissions by half before 2030 and to reach net-zero targets before 2050.

Collaborating with several influential partners, including CDP, the United Nations Global Compact, and the World Resources Institute, the SBTi leads the charge in promoting best practices in emission target setting. It provides vital resources and guidance to facilitate the adoption of these principles among businesses worldwide.

About Systemair

Systemair stands tall as a premier ventilation solutions provider, operating across 51 nations worldwide, including regions such as Europe, North America, and Asia-Pacific. The company reported a remarkable turnover of SEK 12.3 billion during the latest financial year and currently employs around 6,600 dedicated individuals.

A pioneer in energy efficiency, Systemair continues to deliver innovative products that enhance indoor air quality while contributing to lower carbon emissions. The company's notable growth rate of approximately 9% annually over the last decade attests to its strong market presence.

Systemair’s shares have been traded on the Nasdaq OMX Nordic Exchange in Stockholm since October 2007, ensuring that the company remains a key player within the Large Cap List, backed by a robust network of approximately 90 subsidiary companies.

Frequently Asked Questions

What are Systemair's emission reduction targets?

Systemair aims to reduce its absolute emissions in scopes 1 and 2 by 42% by fiscal year 2030/31 and scope 3 by 25% within the same timeframe.

How does Systemair plan to achieve net-zero emissions?

Systemair plans to reduce overall emissions by 90% and attain net-zero greenhouse gas emissions by fiscal year 2050/51.

Why is energy efficiency important to Systemair?

Energy efficiency is crucial for minimizing unnecessary energy use, especially as the world transitions to cleaner technologies and reduces fossil fuel reliance.

What is the role of the Science Based Targets Initiative?

The SBTi helps businesses set science-based emission reduction targets, ensuring their goals align with climate science for effective global warming mitigation.

Where is Systemair based?

Systemair operates in 51 countries globally, specializing in ventilation solutions to improve indoor climates.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 8

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 5

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 4

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 6

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

AllianceBernstein Sees Rise in Assets Under Management

Updated Category News Views 244

AllianceBernstein's Recent Growth in Assets Under Management Investment management firm AllianceBernstein L.P. (NYSE: AB) is celebrating a significant milestone, as it announced preliminary assets under management (AUM) surged to $844 billion during the recent reporting period. This marks a notable increase from $830 billion just a month prior, reflecting robust firmwide...

Continue Reading
Mattamy Group Corporation Reveals Impressive Q3 Operational Metrics

Updated Category News Views 536

Mattamy Group Corporation's Operational Insights for the Quarter Mattamy Group Corporation, recognized as one of the largest privately owned homebuilders in North America, shared essential operational results for its third quarter. This update reflects the company's performance in a competitive market and emphasizes its commitment to homeownership. Key Highlights from...

Continue Reading
Legal Challenges for Fermi Inc. as Investors Seek Justice

Updated Category News Views 150

Fermi Inc. Faces Legal Issues Following IPO Fermi Inc. (NASDAQ: FRMI) is currently embroiled in a proposed securities class action that has captured the attention of the investment community. This follows their recent initial public offering, which came just before a troubling announcement regarding a significant agreement related to their Project Matador. Understanding...

Continue Reading
Microfluidic Chips Market Growth Driven by Innovation and Demand

Updated Category News Views 72

Microfluidic Chips Market Overview The microfluidic chips market is on an upward trajectory, with projections indicating it will reach an impressive USD 8770.5 million by 2030. This growth reflects a strong compound annual growth rate (CAGR) of 10.1%. These cutting-edge devices are making significant impacts across various fields, including healthcare, pharmaceuticals,...

Continue Reading
Citi Boosts Becton Dickinson Stock Rating: Optimism Ahead

Updated Category News Views 70

Citi’s Upgrade of Becton Dickinson's Stock Recently, Becton Dickinson (NYSE: BDX), a leading medical technology firm, witnessed an encouraging upgrade in its stock rating by Citi, which elevated its classification from Neutral to Buy. This revision was also accompanied by an increase in the price target, now set at $275, up from the earlier target of $255. Understanding...

Continue Reading